During Friday’s Current trade, Shares of ADTRAN, Inc. (NASDAQ:ADTN), lost -1.37% to $16.54.
ADTRAN, Inc. (ADTN) stated results for the second quarter 2015. For the quarter, sales were $160,138,000 contrast to $176,129,000 for the second quarter of 2014. Net income was $2,544,000 contrast to $14,395,000 for the second quarter of 2014. Earnings per share, assuming dilution, were $0.05 contrast to $0.26 for the second quarter of 2014. Non-GAAP earnings per share were $0.10 contrast to $0.30 for the second quarter of 2014. The reconciliation between GAAP earnings per share, diluted, and non-GAAP earnings per share, diluted, is in the table offered.
The Company also declared that its Board of Directors declared a cash dividend for the second quarter of 2015. The quarterly cash dividend is $0.09 per common share to be paid to holders of record at the close of business on July 30, 2015. The ex-dividend date is July 28, 2015 and the payment date is August 13, 2015.
ADTRAN, Inc. manufactures and sells networking and communications equipment worldwide. It operates in two divisions, Carrier Networks and Enterprise Networks. The Carrier Networks division provides broadband access products, such as multi-service access nodes, fiber to the nodes, digital subscriber line access multiplexer products, and distribution point units; optical products, counting optical networking edge, fiber Ethernet access devices, multi-service edge switches, multi-service provisioning platforms, and pluggable optical products; and time division multiplexed (TDM) systems under the Total Access and hiX brand names.
Shares of Sensata Technologies Holding N.V. (NYSE:ST), declined -0.24% to $50.85, during its current trading session.
Sensata Technologies Holding N.V. (ST) will issue a press release announcing its financial results for the second quarter ended June 30, 2015 on Tuesday, July 28, 2015.
Sensata will conduct a conference call on the same day at 8:00 a.m. Eastern Time to talk about the results.
Sensata Technologies Holding N.V., through its auxiliaries, develops, manufactures, and sells sensors and controls. It operates in two segments, Sensors and Controls. The Sensors segment manufactures pressure, temperature, speed, position, and force sensors, in addition to electromechanical sensors. Its products are used in subsystems of automobiles, such as engine, air conditioning, and ride stabilization; heavy off-road vehicles; and systems that address safety and environmental concerns.
Agilent Technologies Inc (NYSE:A), during its Friday’s current trading session decreased -0.69% to $40.06.
Agilent Technologies Inc. ( A) declared that Dr. Lawrence J. Lesko has received an Agilent Thought Leader Award in support of his research into preclinical toxicological assessments of new medicines.
An internationally recognized pharmacologist, Dr. Lesko directs the Center for Pharmacometrics and Systems Pharmacology at the University of Florida’s College of Pharmacy in Orlando .
Dr. Lesko and his team are using Agilent accurate mass Q-TOF LC/MS to collect and analyze metabolomics data. With the assist of Agilent’s Mass Profiler Professional and Pathway Architect software, they hope to discover biomarker panels that could enable the development of future companion diagnostics.
Agilent Technologies, Inc. provides bio-analytical solutions and services to the life sciences, diagnostics and genomics, chemical analysis, communications, and electronics industries worldwide. The company’s Life Sciences and Diagnostics segment offers liquid chromatography systems, columns, and components; liquid chromatography mass spectrometry systems; laboratory software and informatics systems; laboratory automation and robotic systems; dissolution testing; nucleic acid solutions; nuclear magnetic resonance, magnetic resonance imaging, and X-ray diffraction systems; immunohistochemistry; in situ hybridization; hematoxylin and eosin staining; special staining, DNA mutation detection; genotyping; gene copy number determination; identification of gene rearrangements; DNA methylation and gene expression profiling; next generation sequencing target enrichment; and automated gel electrophoresis-based sample analysis systems.
Finally, Cowen Group Inc (NASDAQ:COWN), gained 0.92%, to $6.57.
Cowen Group, Inc. (COWN) and Concept Capital Markets, LLC (“Concept Capital”) recently declared the signing of a definitive agreement under which Cowen will acquire Concept Capital, a leading independent provider of prime brokerage services. While financial terms of the deal were not revealed, Cowen Group anticipates the acquisition to be accretive to earnings in 2015. The transaction was approved by the board of directors of both companies.
The transaction is predictable to close in the third quarter of 2015 and is subject to customary closing conditions and regulatory approval.
Willkie Farr & Gallagher LLP acted as legal advisor to Cowen and Seward & Kissel LLP acted as legal advisor to Concept Capital on this transaction.
Cowen Group, Inc. is a publicly owned asset administration holding company. Through its auxiliaries, the firm provides alternative investment administration, investment banking, research, and sales and trading services for its clients. It manages separate client focused portfolio through its auxiliaries.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
